Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Grifols S.A. ADR (GRFS)

Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain PR Newswire - Tue May 23, 2023

/PRNewswire/ -- DelveInsight's 'Dry Eye Disease Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline dry eye disease therapies in...

GRFS : 6.39 (-1.39%)
Why Shares of Grifols Were Up Tuesday Motley Fool - Tue May 9, 2023

The company gave first-quarter numbers.

GRFS : 6.39 (-1.39%)
Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 PR Newswire - Tue Apr 18, 2023

/PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived...

GRF : 9.51 (+0.96%)
GRFS : 6.39 (-1.39%)
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Zacks - Thu Mar 23, 2023

Sector ETF report for FBT

FBT : 145.35 (+0.26%)
MRNA : 108.85 (+0.89%)
IBB : 127.76 (-0.20%)
GRFS : 6.39 (-1.39%)
EXAS : 63.24 (-0.46%)
XBI : 83.94 (-0.89%)
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? Zacks - Thu Mar 16, 2023

Smart Beta ETF report for FBT

FBT : 145.35 (+0.26%)
MRNA : 108.85 (+0.89%)
IBB : 127.76 (-0.20%)
GRFS : 6.39 (-1.39%)
EXAS : 63.24 (-0.46%)
XBI : 83.94 (-0.89%)
Are Investors Undervaluing Grifols (GRFS) Right Now? Zacks - Wed Mar 15, 2023

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

GRFS : 6.39 (-1.39%)
Grifols (GRFS) Upgraded to Strong Buy: Here's Why Zacks - Tue Mar 7, 2023

Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

GRFS : 6.39 (-1.39%)
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease PR Newswire - Mon Mar 6, 2023

/PRNewswire/ -- Selagine, Inc., a spin-out company from the University of Illinois at Chicago (UIC), announced today that it has entered into a research,...

GRFS : 6.39 (-1.39%)
Is Grifols (GRFS) Stock Undervalued Right Now? Zacks - Mon Feb 27, 2023

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

GRFS : 6.39 (-1.39%)
TAK : 13.23 (-1.12%)
Is Grifols (GRFS) a Great Value Stock Right Now? Zacks - Fri Feb 10, 2023

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

GRFS : 6.39 (-1.39%)

Barchart Exclusives

1 Stock to Profit from the U.S. Infrastructure Spending Bonanza Barchart - 41 minutes ago
The poor state of U.S. infrastructure is why the government has allocated trillions of dollars in federal funding towards upgrading it. While this spending is good for the country, it will be great for the companies that supply construction materials - like aggregates and concrete giant Vulcan Materials. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot